Je was op zoek naar: hydroxyurea (Engels - Deens)

hydroxyurea
hydroxyurinstof

prior hydroxyurea
tidligere hydroxyurea

prior hydroxyurea prior interferon prior bone marrow transplant
tidligere hydroxyurea tidligere interferon tidligere knoglemarvstransplantation

it may be given with hydroxyurea or anagrelide if clinically indicated.
det kan gives med hydroxyurea eller anagrelid, hvis dette er klinisk indiceret.

tasigna may be given with hydroxyurea or anagrelide if clinically indicated.
tasigna kan gives med hydroxyurea eller anagrelid, hvis dette er klinisk indiceret.

hence, hydroxyurea should not be used in the treatment of hiv infection.
derfor bør hydroxycarbamid ikke anvendes under behandling af hiv infektion.

to compare the average time to response following treatment with anagrelide or hydroxyurea.
at sammenligne den gennemsnitlige periode til respons efter behandling med anagrelid eller hydroxyurea.

on the contrary, gallates protected rabbits against the teratogenic potential of hydroxyurea.
gallater beskyttede tværtimod kaniner mod hydroxy­ureas teratogene virkninger.

when introna is used with hydroxyurea, the frequency and severity of cutaneous vasculitis may be increased.
når introna anvendes med hydroxyurinstof, kan hyppigheden og sværhedsgraden af kutan vasculitis øges.

to compare the cytoreductive impact of anagrelide and hydroxyurea on white blood cell and red blood cell lines.
at sammenligne den cytoreduktive virkning af anagrelid og hydroxyurea på hvide blodceller og røde blodceller.

to compare the efficacy of anagrelide and hydroxyurea in terms of the platelet count after 3 months of treatment.
at sammenligne virkningen af anagrelid og hydroxyurea med hensyn til trombocyttal efter 3 måneders behandling.

effects of anagrelide and hydroxyurea when given in combination demonstrated no adverse effects on the kinetics of either medicinal product.
de potentielle virkninger af anagrelid og hydroxyurea ved indgivelse i kombination påviste ingen negative virkninger på nogen af lægemidlernes kinetik.

most of these patients had histories of extended treatment with hydroxyurea and prior nmsc or pre-malignant skin lesions.
de fleste af disse patienter havde været i langvarig behandling med hydroxycarbamid og havde non-melanom hudkræft eller præmaligne hudlæsioner i anamnesen.

in polycythaemia vera, jakavi was studied in one main study which involved 222 patients who were resistant or intolerant to treatment with hydroxyurea.
hvad angår polycythæmia vera blev jakavi undersøgt i en hovedundersøgelse med 222 patienter, som var resistente over for eller ikke tåler behandling med hydroxyurea.

a phase iiib, randomised study to compare the efficacy, tolerability and safety of anagrelide hydrochloride versus hydroxyurea in high-risk patients with essential thrombocythaemia.
en randomiseret fase iiib undersøgelse til sammenligning af virkning, tolerans og sikkerhed for anagrelid hydroklorid vs hydroxyurea hos højrisikopatienter med essentiel trombocytæmi.

a phase iiib, randomised study to compare the efficacy, tolerability and safety of anagrelide hydrochloride versus hydroxyurea in high-risk patients with essential thrombocythaemia.objectives:
en randomiseret fase iiib undersøgelse til sammenligning af

hepatotoxicity and hepatic failure resulting in death were reported during postmarketing surveillance in hiv infected patients treated with antiretroviral agents and hydroxyurea; fatal hepatic events were reported most often in patients treated with stavudine, hydroxyurea and didanosine.
levertoksicitet og leversvigt, som har resulteret i dødsfald, har været rapporteret under overvågning efter markedsføring hos hiv smittede patienter, som har været i behandling med antiretrovirale midler og hydroxycarbamid; de fatale levertilfælde blev oftest rapporteret hos patienter i behandling med stavudin, hydroxycarbamid og didanosin.

hydroxycarbamide, which used to be known as hydroxyurea, has been available in the european union (eu) for several decades for use in other illnesses, including some types of cancer.
hydroxycarbamid, som tidligere var kendt under navnet hydroxyurea, har været på markedet i eu i flere årtier til behandling af andre sygdomme, bl.a. visse former for kræft.

not recommended combinations: pancreatitis (fatal and nonfatal) and peripheral neuropathy (severe in some cases) have been reported in hiv infected patients receiving stavudine in association with hydroxyurea and didanosine.
kombinationer som ikke kan anbefales: pancreatitis (fatal og ikke fatal) og perifer neuropati (alvorlig i nogle tilfælde) er blevet rapporteret hos hiv smittede patienter, som har fået stavudin samtidig med hydroxycarbamid og didanosin.